Home LiteratureArticle Details
PMID: 20346152 Published · epublish English Journal Article Research Support, N.I.H., Extramural

Inhibition of AMPA receptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution.

Molecular brain ·Vol. 3 ·2010-03-26 ·Pages 10

Rui Y, Gu J, Yu K, Hartzell HC, Zheng JQ

Abstract

Synaptic defects represent a major mechanism underlying altered brain functions of patients suffering Alzheimer's disease (AD) 123. An increasing body of work indicates that the oligomeric forms of beta-amyloid (Abeta) molecules exert profound inhibition on synaptic functions and can cause a significant loss of neurotransmitter receptors from the postsynaptic surface, but the underlying mechanisms remain poorly understood. In this study, we investigated a potential contribution of mitochondria to Abeta inhibition of AMPA receptor (AMPAR) trafficking. We found that a brief exposure of hippocampal neurons to Abeta oligomers not only led to marked removal of AMPARs from postsynaptic surface but also impaired rapid AMPAR insertion during chemically-induced synaptic potentiation. We also found that Abeta oligomers exerted acute impairment of fast mitochondrial transport, as well as mitochondrial translocation into dendritic spines in response to repetitive membrane depolarization. Quantitative analyses at the single spine level showed a positive correlation between spine-mitochondria association and the surface accumulation of AMPARs. In particular, we found that spines associated with mitochondria tended to be more resistant to Abeta inhibition on AMPAR trafficking. Finally, we showed that inhibition of GSK3beta alleviated Abeta impairment of mitochondrial transport, and effectively abolished Abeta-induced AMPAR loss and inhibition of AMPAR insertion at spines during cLTP. Our findings indicate that mitochondrial association with dendritic spines may play an important role in supporting AMPAR presence on or trafficking to the postsynaptic membrane. Abeta disruption of mitochondrial trafficking could contribute to AMPAR removal and trafficking defects leading to synaptic inhibition.

MeSH Terms
Alzheimer Disease/metabolism,pathology,physiopathology Amyloid beta-Peptides/chemistry,genetics,metabolism Animals Cells, Cultured Dendritic Spines/metabolism Hippocampus/cytology,metabolism Humans Mitochondria/metabolism Neurons/cytology,metabolism Patch-Clamp Techniques Protein Multimerization Protein Structure, Quaternary Rats Receptors, AMPA/metabolism Synapses/metabolism
Chemicals
Amyloid beta-Peptides Receptors, AMPA
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Rui Yanfang
Departments of Cell Biology and Neurology, Center for Neurodegenerative Diseases, Emory University School of Medicine, Atlanta, GA 30322, USA.
Gu Jiaping
Yu Kuai
Hartzell H Criss
Zheng James Q
References (53)
53 references, click to expand
  1. Rat hippocampal neurons in dispersed cell culture.
    Brain Res. 1977 May 13;126(3):397-42 PMID: 861729
  2. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics.
    Annu Rev Pharmacol Toxicol. 2003;43:545-84 PMID: 12415125
  3. Mitochondria in neuroplasticity and neurological disorders.
    Neuron. 2008 Dec 10;60(5):748-66 PMID: 19081372
  4. WAVE1 controls neuronal activity-induced mitochondrial distribution in dendritic spines.
    Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3112-6 PMID: 18287015
  5. Mitochondrial fission proteins regulate programmed cell death in yeast.
    Genes Dev. 2004 Nov 15;18(22):2785-97 PMID: 15520274
  6. Synaptic pathology of Alzheimer's disease.
    Ann N Y Acad Sci. 1993 Sep 24;695:59-64 PMID: 8239314
  7. Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies.
    Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S21-6 PMID: 9330981
  8. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta.
    J Neurochem. 2003 Dec;87(5):1152-64 PMID: 14622095
  9. Receptor trafficking and synaptic plasticity.
    Nat Rev Neurosci. 2004 Dec;5(12):952-62 PMID: 15550950
  10. Synaptic pathology in Alzheimer's disease: relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele.
    J Neural Transm (Vienna). 1996;103(5):603-18 PMID: 8811505
  11. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses.
    Cell. 2004 Dec 17;119(6):873-87 PMID: 15607982
  12. Amyloid, the presenilins and Alzheimer's disease.
    Trends Neurosci. 1997 Apr;20(4):154-9 PMID: 9106355
  13. Mitochondrial Ca2+ signalling in hippocampal neurons.
    Cell Calcium. 2008 Mar;43(3):296-306 PMID: 17764739
  14. Fueling synapses.
    Cell. 2004 Dec 17;119(6):738-40 PMID: 15607970
  15. Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms.
    J Neurosci. 2003 Oct 1;23(26):8967-77 PMID: 14523099
  16. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.
    Am J Pathol. 2008 Mar;172(3):786-98 PMID: 18258852
  17. Alzheimer's disease is a synaptic failure.
    Science. 2002 Oct 25;298(5594):789-91 PMID: 12399581
  18. Role of AMPA receptor cycling in synaptic transmission and plasticity.
    Neuron. 1999 Nov;24(3):649-58 PMID: 10595516
  19. Mitochondrial involvement in post-tetanic potentiation of synaptic transmission.
    Neuron. 1997 Mar;18(3):483-91 PMID: 9115741
  20. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.
    J Biol Chem. 2002 Aug 30;277(35):32046-53 PMID: 12058030
  21. The molecular basis of CaMKII function in synaptic and behavioural memory.
    Nat Rev Neurosci. 2002 Mar;3(3):175-90 PMID: 11994750
  22. AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice.
    Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3410-5 PMID: 16492745
  23. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription.
    Chem Biol. 2000 Oct;7(10):793-803 PMID: 11033082
  24. PICK1 and phosphorylation of the glutamate receptor 2 (GluR2) AMPA receptor subunit regulates GluR2 recycling after NMDA receptor-induced internalization.
    J Neurosci. 2007 Dec 12;27(50):13903-8 PMID: 18077702
  25. AMPA receptor trafficking at excitatory synapses.
    Neuron. 2003 Oct 9;40(2):361-79 PMID: 14556714
  26. The GSK3 hypothesis of Alzheimer's disease.
    J Neurochem. 2008 Mar;104(6):1433-9 PMID: 18088381
  27. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
    Nat Med. 2008 Aug;14(8):837-42 PMID: 18568035
  28. {beta}-Amyloid impairs AMPA receptor trafficking and function by reducing Ca2+/calmodulin-dependent protein kinase II synaptic distribution.
    J Biol Chem. 2009 Apr 17;284(16):10639-49 PMID: 19240035
  29. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.
    Nature. 2002 Apr 4;416(6880):535-9 PMID: 11932745
  30. Mitochondrial trafficking to synapses in cultured primary cortical neurons.
    J Neurosci. 2006 Jun 28;26(26):7035-45 PMID: 16807333
  31. AMPA receptor trafficking and synaptic plasticity.
    Annu Rev Neurosci. 2002;25:103-26 PMID: 12052905
  32. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.
    Biochem Biophys Res Commun. 1984 May 16;120(3):885-90 PMID: 6375662
  33. Translating cell biology into therapeutic advances in Alzheimer's disease.
    Nature. 1999 Jun 24;399(6738 Suppl):A23-31 PMID: 10392577
  34. Regulation of NMDA receptor trafficking by amyloid-beta.
    Nat Neurosci. 2005 Aug;8(8):1051-8 PMID: 16025111
  35. Regulation of AMPA receptors during synaptic plasticity.
    Trends Neurosci. 2002 Nov;25(11):578-88 PMID: 12392933
  36. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death.
    J Neurochem. 2001 Apr;77(1):94-102 PMID: 11279265
  37. Imaging axonal transport of mitochondria.
    Methods Enzymol. 2009;457:319-33 PMID: 19426876
  38. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.
    Brain Res. 2002 Jan 11;924(2):133-40 PMID: 11750898
  39. Roles of serine/threonine phosphatases in hippocampal synaptic plasticity.
    Nat Rev Neurosci. 2001 Jul;2(7):461-74 PMID: 11433371
  40. Tau pathology: a marker of neurodegenerative disorders.
    Curr Opin Neurol. 2000 Aug;13(4):371-6 PMID: 10970052
  41. Synaptic and intrinsic mechanisms shape synchronous oscillations in hippocampal neurons in culture.
    Eur J Neurosci. 1999 Feb;11(2):389-97 PMID: 10051739
  42. Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
    J Neurosci. 2004 Nov 10;24(45):10191-200 PMID: 15537891
  43. Use-dependent effects of amyloidogenic fragments of (beta)-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo.
    J Neurosci. 2001 Feb 15;21(4):1327-33 PMID: 11160403
  44. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders.
    Nat Rev Neurosci. 2007 Jun;8(6):413-26 PMID: 17514195
  45. Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake.
    Neuron. 2009 Jun 25;62(6):788-801 PMID: 19555648
  46. Synaptic plasticity and AMPA receptor trafficking.
    Ann N Y Acad Sci. 2003 Nov;1003:1-11 PMID: 14684431
  47. Mitochondrial dynamics and division in budding yeast.
    Trends Cell Biol. 2002 Apr;12(4):178-84 PMID: 11978537
  48. Pathways towards and away from Alzheimer's disease.
    Nature. 2004 Aug 5;430(7000):631-9 PMID: 15295589
  49. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons.
    J Neurosci. 2006 Oct 11;26(41):10480-7 PMID: 17035532
  50. The use of pHluorins for optical measurements of presynaptic activity.
    Biophys J. 2000 Oct;79(4):2199-208 PMID: 11023924
  51. Folding proteins in fatal ways.
    Nature. 2003 Dec 18;426(6968):900-4 PMID: 14685251
  52. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.
    Neuron. 2006 Dec 7;52(5):831-43 PMID: 17145504
  53. Novel form of long-term potentiation produced by a K+ channel blocker in the hippocampus.
    Nature. 1991 Jan 3;349(6304):67-9 PMID: 1845914
Article Info
Journal
Molecular brain
Abbr.
Mol Brain
ISSN
1756-6606
Published
2010-03-26
Epub
2010-00-26
Pages
10
Language
English
Region
England
NLM ID
101468876
PMCID
PMC2853530
Subset
IM
Grants
NIGMS NIH HHS · GM084363 · United States
NIGMS NIH HHS · R01 GM060448-08 · United States
NIA NIH HHS · AG029596 · United States
NEI NIH HHS · R01 EY014852-08 · United States
NIGMS NIH HHS · GM083889 · United States
NIGMS NIH HHS · R01 GM060448 · United States
NEI NIH HHS · EY014852 · United States
NIA NIH HHS · P50 AG025688 · United States
NEI NIH HHS · R01 EY014852 · United States
NIGMS NIH HHS · GM60448 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com